Pilulka Lékárny a.s. (PRA:PINK)
110.00
+3.00 (2.80%)
Jul 31, 2026, 3:02 PM CET
Pilulka Lékárny a.s. Balance Sheet
Financials in millions CZK. Fiscal year is January - December.
Millions CZK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 31.28 | 20.34 | 21.69 | 41.35 | 71.61 |
Cash & Short-Term Investments | 31.28 | 20.34 | 21.69 | 41.35 | 71.61 |
Cash Growth | 53.79% | -6.23% | -47.53% | -42.26% | -45.66% |
Accounts Receivable | 39.33 | 67.45 | 130.03 | 136.71 | - |
Other Receivables | 25.37 | 13.81 | 43.64 | 1.1 | 184.71 |
Total Trade Receivables | 64.7 | 81.26 | 173.66 | 137.81 | 184.71 |
Inventory | 63.38 | 54.74 | 96.17 | 187.21 | 155.25 |
Other Current Assets | 1.44 | 2.83 | 4.34 | 3.78 | - |
Total Current Assets | 143.72 | 146.17 | 279.92 | 405.28 | 411.57 |
Net Property, Plant & Equipment | 9.01 | 21.14 | 57.63 | 74.36 | 62.43 |
Other Intangible Assets | 22.71 | 39 | 67.33 | 89.77 | 82.81 |
Goodwill | 16.73 | 19.02 | 21.32 | 23.78 | 25.9 |
Long-Term Investments | 3.54 | 9.18 | 9.17 | 9.18 | 4.05 |
Other Long-Term Assets | 1.44 | 2.83 | 4.34 | 3.78 | 2.38 |
Total Assets | 197.15 | 237.34 | 439.7 | 605.96 | 589.14 |
Accounts Payable | 251.96 | 161.69 | 279.42 | 339.59 | - |
Accrued Expenses | 13.43 | 26.22 | 38.77 | 30.85 | - |
Short-Term Debt | 55.3 | 48.45 | 77 | 59.96 | 21.34 |
Current Portion of Long-Term Debt | 0 | 85.56 | 0 | - | - |
Unearned Revenue | 10.55 | 7.42 | 4.64 | 3.24 | - |
Other Current Liabilities | 3.81 | 4.76 | 9.14 | 8.49 | 15.89 |
Total Current Liabilities | 330.04 | 326.94 | 396.15 | 433.63 | 347.69 |
Long-Term Debt | - | - | - | 24.8 | - |
Other Long-Term Liabilities | - | - | 0.22 | 0.25 | - |
Total Long-Term Liabilities | 1.2 | 2.4 | 3.79 | 24.93 | 21.45 |
Total Liabilities | 331.24 | 329.34 | 399.93 | 458.56 | 753.26 |
Common Stock | 2.71 | 2.71 | 2.71 | 2.52 | 2.5 |
Additional Paid-in Capital | 455.91 | 455.91 | 455.91 | 388.71 | 390.29 |
Retained Earnings | -553.59 | -426.85 | -250.83 | -186.16 | -213.91 |
Total Common Shareholders' Equity | -133.84 | -93.98 | 32.85 | 140.14 | 204.38 |
Minority Interest | -8.12 | -5.55 | -4.28 | -2.41 | -0.55 |
Shareholders' Equity | -141.96 | -99.52 | 28.57 | 137.73 | 203.83 |
Total Liabilities & Equity | 197.15 | 237.34 | 439.7 | 605.96 | 589.14 |
Total Debt | 55.3 | 134.01 | 77 | 84.76 | 21.34 |
Net Cash (Debt) | -24.02 | -113.67 | -55.31 | -43.41 | 50.26 |
Net Cash Growth | - | - | - | - | -53.10% |
Net Cash Per Share | -8.87 | -42.00 | -20.43 | -17.22 | 20.11 |
Book Value | -133.84 | -93.98 | 32.85 | 140.14 | 204.38 |
Book Value Per Share | -49.45 | -34.72 | 12.14 | 55.59 | 81.75 |
Tangible Book Value | -173.28 | -152 | -55.8 | 26.59 | 95.67 |
Tangible Book Value Per Share | -64.02 | -56.16 | -20.62 | 10.55 | 38.27 |